John Schembri, See Remarks at Global Blood Therapeutics, Inc. (GBT), bought 1,500 shares at $20.00 ($32K) on 2015-08-17, disclosed to the SEC on 2016-01-07.
Open-market purchase of $32k GBT by See Remarks. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.00 | 500 | $10K | 30.9% |
| 2 | $22.36 | 1,000 | $22K | 69.1% |
| Total | $21.57 avg | 1,500 | $32K | 100% |